Varicella can cause complications that are potentially serious and require hospitalization. Our current understanding of the causes and incidence of varicella-related hospitalization in Turkey is limited and sufficiently accurate epidemiological and economical information is lacking. The aim of this study was to estimate the annual incidence of varicella-related hospitalizations, describe the complications, and estimate the annual mortality and cost of varicella in children. VARICOMP is a multi-center study that was performed to provide epidemiological and economic data on hospitalization for varicella in children between 0 and 15 years of age from October 2008 to September 2010 in Turkey. According to medical records from 27 health care centers in 14 cities (representing 49.3% of the childhood population in Turkey), 824 children (73% previously healthy) were hospitalized for varicella over the 2-year period. Most cases occurred in the spring and early summer months. Most cases were in children under 5 years of age, and 29.5% were in children under 1 year of age. The estimated incidence of varicella-related hospitalization was 5.29-6.89 per 100,000 in all children between 0-15 years of age in Turkey, 21.7 to 28 per 100,000 children under 1 year of age, 9.8-13.8 per 100,000 children under 5 years of age, 3.96-6.52 per 100,000 children between 5 and 10 years of age and 0.42 to 0.71 per 100,000 children between 10 and 15 years of age. Among the 824 children, 212 (25.7%) were hospitalized because of primary varicella infection. The most common complications in children were secondary bacterial infection (23%), neurological (19.1%), and respiratory (17.5%) complications. Secondary bacterial infections (p < 0.001) and neurological complications (p < 0.001) were significantly more common in previously healthy children, whereas hematological complications (p < 0.001) were more commonly observed in children with underlying conditions. The median length of the hospital stay was 6 days, and it was longer in children with underlying conditions (<0.001). The median cost of hospitalization per patient was $338 and was significantly higher in children with underlying conditions (p < 0.001). The estimated direct annual cost (not including the loss of parental work time and school absence) of varicella-related hospitalization in children under the age of 15 years in Turkey was $856,190 to $1,407,006. According to our estimates, 882 to 1,450 children are hospitalized for varicella each year, reflecting a population-wide occurrence of 466-768 varicella cases per 100,000 children. In conclusion, this study confirms that varicella-related hospitalizations are not uncommon in children, and two thirds of these children are otherwise healthy. The annual cost of hospitalization for varicella reflects only a small part of the overall cost of this disease, as only a very few cases require hospital admission. The incidence of this disease was higher in children <1 year of age, and there are no prevention strategies for these children other ...
Epidemiological and Clinical Characteristics of Pandemic Influenza A (H1N1)v Infection Among the Children Admitted to Süleyman Demirel UniversityAbstract Aim: We aimed to evaluate the clinical and epidemiological features of the patients that were admitted to Suleyman Demirel University Medical Faculty Pediatric Department, for whom the pre-diagnosis was H1N1v. Material and Methods: Demographic characteristics, clinical findings, laboratory tests results and radiological evaluations of 64 patients who were admitted to Suleyman Demirel University Medical Faculty Pediatric Department with pre-diagnosis of H1N1v were analyzed and evaluated. Findings: Average age of the patients who were admitted and observed with pre-diagnosis of pandemic influenza, was 32,4 months (1-188 months) and 34% (n=22) of the cases were female. Nine of the patients (14%) were confirmed for final diagnosis as H1N1v. Most common complaints during admission were cough (85,9%), fever (68,%) and weakness (57,8%). Five of the patients (55%) that are H1N1v positive had preexisting diseases. Five patients needed intensive care unit during the observation and treatment. Two (22,2%) of them did not survive. Results: Clinical findings of pandemic influenza and seasonal influenza are quite similar. Preexisting diseases increase the rates of morbidity and mortality.
Objective Our study evaluates the epidemiological and demographics of the children who were admitted to Süleyman Demirel University, Medical Faculty, Paediatrics Department with the pre-diagnosis of pandemic influenza. Methods and Materials Demographic characteristics, clinical findings, laboratory tests results and radiological researchs of 64 patients (n = 64), who were admitted to Süleyman Demirel University, Medical Faculty Paediatric Department with the pre-diagnosis of pandemic influenza were analysed and evaluated. Results Average age of the patients, that were admitted and observed with pre-diagnosis of pandemical influenza, was 32.4 months (1–188 months) and 34% (n = 22) of the cases were female. H1N1v diagnosis was confirmed in 14% (n = 9) of the patients with pre-diagnosis of pandemiz influenza. Most common complaints during submission were severe cough (85.9%), fever (68.8%) and weakness (57.8%). Among the the patients who were H1N1v positive, 55% (n = 5) of them, had preexisting diseases. Five patients needed intensive care during the observation and treatment. Two (22.2%) of them did not survive. Conclusion Clinical findings of pandemical influenza and seasonal influenza are quite similar in children. Pre-existing diseases increase the rates of morbidity and mortality.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.